Innovage Holding Corp Stock EBITDA
| INNV Stock | USD 4.44 0.11 2.54% |
InnovAge Holding Corp fundamentals help investors to digest information that contributes to InnovAge Holding's financial success or failures. It also enables traders to predict the movement of InnovAge Stock. The fundamental analysis module provides a way to measure InnovAge Holding's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to InnovAge Holding stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -33.9 M | -32.2 M |
InnovAge | EBITDA |
InnovAge Holding Corp Company EBITDA Analysis
InnovAge Holding's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current InnovAge Holding EBITDA | (33.85 M) |
Most of InnovAge Holding's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, InnovAge Holding Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
InnovAge EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for InnovAge Holding is extremely important. It helps to project a fair market value of InnovAge Stock properly, considering its historical fundamentals such as EBITDA. Since InnovAge Holding's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of InnovAge Holding's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of InnovAge Holding's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
InnovAge Ebitda
According to the company disclosure, InnovAge Holding Corp reported earnings before interest,tax, depreciation and amortization of (33.85 Million). This is 103.86% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The ebitda for all United States stocks is 100.87% higher than that of the company.
InnovAge EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses InnovAge Holding's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of InnovAge Holding could also be used in its relative valuation, which is a method of valuing InnovAge Holding by comparing valuation metrics of similar companies.InnovAge Holding is currently under evaluation in ebitda category among related companies.
InnovAge Holding ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, InnovAge Holding's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to InnovAge Holding's managers, analysts, and investors.Environmental | Governance | Social |
InnovAge Holding Institutional Holders
Institutional Holdings refers to the ownership stake in InnovAge Holding that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of InnovAge Holding's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing InnovAge Holding's value.| Shares | Renaissance Technologies Corp | 2023-12-31 | 129.8 K | Exoduspoint Capital Management, Lp | 2023-12-31 | 77.8 K | Strs Ohio | 2023-12-31 | 69.8 K | Nuveen Asset Management, Llc | 2023-12-31 | 53.4 K | Bank Of New York Mellon Corp | 2023-12-31 | 48.1 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 37.8 K | Goldman Sachs Group Inc | 2023-12-31 | 36.7 K | Alliancebernstein L.p. | 2024-03-31 | 33.2 K | Bank Of America Corp | 2023-12-31 | 27.3 K | T. Rowe Price Investment Management,inc. | 2023-12-31 | 4.7 M | Coliseum Capital Management Llc | 2024-03-31 | 4.5 M |
InnovAge Fundamentals
| Return On Equity | -0.11 | ||||
| Return On Asset | -0.0332 | ||||
| Profit Margin | (0.04) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 633.56 M | ||||
| Shares Outstanding | 135.99 M | ||||
| Shares Owned By Insiders | 80.99 % | ||||
| Shares Owned By Institutions | 12.31 % | ||||
| Number Of Shares Shorted | 379.18 K | ||||
| Price To Earning | 33.64 X | ||||
| Price To Book | 1.86 X | ||||
| Price To Sales | 0.74 X | ||||
| Revenue | 688.09 M | ||||
| Gross Profit | 475.82 M | ||||
| EBITDA | (33.85 M) | ||||
| Net Income | (43.55 M) | ||||
| Cash And Equivalents | 184.43 M | ||||
| Cash Per Share | 1.36 X | ||||
| Total Debt | 108.83 M | ||||
| Debt To Equity | 0.24 % | ||||
| Current Ratio | 2.29 X | ||||
| Book Value Per Share | 2.07 X | ||||
| Cash Flow From Operations | 20.24 M | ||||
| Short Ratio | 11.48 X | ||||
| Earnings Per Share | (0.22) X | ||||
| Target Price | 6.0 | ||||
| Number Of Employees | 2.1 K | ||||
| Beta | 0.23 | ||||
| Market Capitalization | 603.79 M | ||||
| Total Asset | 567.36 M | ||||
| Retained Earnings | (35.94 M) | ||||
| Working Capital | 66.78 M | ||||
| Current Asset | 3.06 M | ||||
| Current Liabilities | 4.22 M | ||||
| Net Asset | 567.36 M |
About InnovAge Holding Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze InnovAge Holding Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InnovAge Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InnovAge Holding Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with InnovAge Holding
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if InnovAge Holding position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InnovAge Holding will appreciate offsetting losses from the drop in the long position's value.Moving together with InnovAge Stock
| 0.79 | AHG | Akso Health Group | PairCorr |
Moving against InnovAge Stock
| 0.64 | GCTK | GlucoTrack | PairCorr |
| 0.53 | NXL | Nexalin Technology | PairCorr |
| 0.45 | WGS | GeneDx Holdings Corp | PairCorr |
The ability to find closely correlated positions to InnovAge Holding could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace InnovAge Holding when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back InnovAge Holding - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling InnovAge Holding Corp to buy it.
The correlation of InnovAge Holding is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InnovAge Holding moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InnovAge Holding Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for InnovAge Holding can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out InnovAge Holding Piotroski F Score and InnovAge Holding Altman Z Score analysis. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for InnovAge Stock analysis
When running InnovAge Holding's price analysis, check to measure InnovAge Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InnovAge Holding is operating at the current time. Most of InnovAge Holding's value examination focuses on studying past and present price action to predict the probability of InnovAge Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InnovAge Holding's price. Additionally, you may evaluate how the addition of InnovAge Holding to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
Is InnovAge Holding's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InnovAge Holding. If investors know InnovAge will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InnovAge Holding listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.88) | Earnings Share (0.22) | Revenue Per Share 5.459 | Quarterly Revenue Growth 0.119 | Return On Assets (0.03) |
The market value of InnovAge Holding Corp is measured differently than its book value, which is the value of InnovAge that is recorded on the company's balance sheet. Investors also form their own opinion of InnovAge Holding's value that differs from its market value or its book value, called intrinsic value, which is InnovAge Holding's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InnovAge Holding's market value can be influenced by many factors that don't directly affect InnovAge Holding's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InnovAge Holding's value and its price as these two are different measures arrived at by different means. Investors typically determine if InnovAge Holding is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InnovAge Holding's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.